| scholarly article | Q13442814 |
| P356 | DOI | 10.1152/AJPHEART.00370.2004 |
| P698 | PubMed publication ID | 15598866 |
| P50 | author | Michael R Zile | Q78851222 |
| P2093 | author name string | Francis G Spinale | |
| Jennifer W Hendrick | |||
| Robert E Stroud | |||
| John S Ikonomidis | |||
| Patricia G Escobar | |||
| Kathryn B Dowdy | |||
| Amanda R Herron | |||
| Elizabeth Hapke | |||
| Andrea M Parkhurst | |||
| P433 | issue | 1 | |
| P921 | main subject | myocardial infarction | Q12152 |
| P304 | page(s) | H149-58 | |
| P577 | publication date | 2005-01-01 | |
| P1433 | published in | American Journal of Physiology Heart and Circulatory Physiology | Q3193662 |
| P1476 | title | Accelerated LV remodeling after myocardial infarction in TIMP-1-deficient mice: effects of exogenous MMP inhibition | |
| P478 | volume | 288 |
| Q30467223 | A bio-telemetric device for measurement of left ventricular pressure-volume loops using the admittance technique in conscious, ambulatory rats |
| Q33699411 | Adenovirus-mediated stromal cell-derived factor-1 alpha gene transfer improves cardiac structure and function after experimental myocardial infarction through angiogenic and antifibrotic actions |
| Q37096257 | Aging and the cardiac collagen matrix: Novel mediators of fibrotic remodelling |
| Q41681985 | An appropriate loading control for western blot analysis in animal models of myocardial ischemic infarction |
| Q37088369 | Aprotinin exacerbates left ventricular dysfunction after ischemia/reperfusion in mice lacking tumor necrosis factor receptor I. |
| Q37175148 | Aprotinin exerts differential and dose-dependent effects on myocardial contractility, oxidative stress, and cytokine release after ischemia-reperfusion |
| Q37175125 | Aprotinin modifies left ventricular contractility and cytokine release after ischemia-reperfusion in a dose-dependent manner in a murine model |
| Q34563950 | Autologous cardiomyotissue implantation promotes myocardial regeneration, decreases infarct size, and improves left ventricular function |
| Q42457121 | Bone marrow mesenchymal stem cell transplantation combined with perindopril treatment attenuates infarction remodelling in a rat model of acute myocardial infarction |
| Q38542448 | Cardiac Physiology of Aging: Extracellular Considerations. |
| Q45786628 | Cardiac fibroblasts protect cardiomyocytes against lethal ischemia-reperfusion injury. |
| Q37688051 | Cardiac fibrosis in mouse expressing DsRed tetramers involves chronic autophagy and proteasome degradation insufficiency. |
| Q34144778 | Cardiac restricted overexpression of membrane type-1 matrix metalloproteinase causes adverse myocardial remodeling following myocardial infarction |
| Q37174508 | Cardiac-restricted overexpression of extracellular matrix metalloproteinase inducer causes myocardial remodeling and dysfunction in aging mice |
| Q37344462 | Cardiac-restricted overexpression of membrane type-1 matrix metalloproteinase in mice: effects on myocardial remodeling with aging |
| Q36357878 | Ceramide synthase 5 mediates lipid-induced autophagy and hypertrophy in cardiomyocytes |
| Q34441099 | Discordant activation of gene promoters for matrix metalloproteinases and tissue inhibitors of the metalloproteinases following myocardial infarction |
| Q36724656 | Drug discovery for heart failure: a new era or the end of the pipeline? |
| Q24658053 | Dynamic correction for parallel conductance, GP, and gain factor, alpha, in invasive murine left ventricular volume measurements |
| Q30314082 | Early citalopram treatment increases mortality due to left ventricular rupture in mice after myocardial infarction |
| Q38423857 | Extracellular matrix communication and turnover in cardiac physiology and pathology |
| Q59790669 | Histone lysine dimethyl-demethylase KDM3A controls pathological cardiac hypertrophy and fibrosis |
| Q37727732 | Hydrogen sulfide suppresses the expression of MMP-8, MMP-13, and TIMP-1 in left ventricles of rats with cardiac volume overload |
| Q84177525 | In vivo measurements of the contributions of protein synthesis and protein degradation in regulating cardiac pressure overload hypertrophy in the mouse |
| Q41169833 | Inhibition of TGF-β1 by eNOS gene transfer provides cardiac protection after myocardial infarction |
| Q37263904 | Inhibition of matrix metalloproteinases improves left ventricular function in mice lacking osteopontin after myocardial infarction. |
| Q35951850 | MT1-MMP-dependent remodeling of cardiac extracellular matrix structure and function following myocardial infarction |
| Q33800230 | Mdivi-1 induced acute changes in the angiogenic profile after ischemia-reperfusion injury in female mice |
| Q33632033 | Membrane-associated matrix proteolysis and heart failure. |
| Q42286488 | Mice with tissue inhibitor of metalloproteinases 4 (Timp4) deletion succumb to induced myocardial infarction but not to cardiac pressure overload. |
| Q37399545 | Molecular imaging targets of cardiac remodeling |
| Q52619556 | Myocardial Infarction Remodeling that Progresses to Heart Failure: A Signaling Misunderstanding. |
| Q37523384 | Myocardial Infarction Superimposed on Aging: MMP-9 Deletion Promotes M2 Macrophage Polarization. |
| Q33663388 | Myofibroblasts and the extracellular matrix network in post-myocardial infarction cardiac remodeling |
| Q34388282 | Periostin facilitates skin sclerosis via PI3K/Akt dependent mechanism in a mouse model of scleroderma. |
| Q87693303 | Playing slot to hitting the jackpot in molecular imaging: On probability of uncovering subcellular pathogenesis vs achieving clinical applicability |
| Q36465034 | Selective translation of mRNAs in the left ventricular myocardium of the mouse in response to acute pressure overload |
| Q37682494 | Systems Genetics Approach Identifies Gene Pathways and Adamts2 as Drivers of Isoproterenol-Induced Cardiac Hypertrophy and Cardiomyopathy in Mice |
| Q53521178 | TIMP-3 deficiency accelerates cardiac remodeling after myocardial infarction. |
| Q33696289 | Targeted overexpression of tissue inhibitor of matrix metalloproteinase-4 modifies post-myocardial infarction remodeling in mice |
| Q26830555 | Targeting matrix metalloproteinases in heart disease: lessons from endogenous inhibitors |
| Q97436055 | Tenascin-C aggravates ventricular dilatation and angiotensin-converting enzyme activity after myocardial infarction in mice |
| Q36308174 | The association between levels of tissue inhibitor of metalloproteinase-1 with acute heart failure and left ventricular dysfunction in patients with ST elevation myocardial infarction treated by primary percutaneous coronary intervention |
| Q89829958 | The compendium of matrix metalloproteinase expression in the left ventricle of mice following myocardial infarction |
| Q36681145 | The design of inhibitors for medicinally relevant metalloproteins |
| Q36312509 | The history of matrix metalloproteinases: milestones, myths, and misperceptions |
| Q33786342 | The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity |
| Q36526033 | Tissue Inhibitor of Metalloproteinase-1: Actions beyond Matrix Metalloproteinase Inhibition. |
| Q42719037 | Tissue inhibitor of metalloproteinase-2 gene delivery ameliorates postinfarction cardiac remodeling |
| Q37895982 | Tissue inhibitor of metalloproteinases (TIMPs) in heart failure |
| Q42692416 | Titin is a target of matrix metalloproteinase-2: implications in myocardial ischemia/reperfusion injury |
| Q35230933 | Toll-like receptor 4 mediates the inflammatory responses and matrix protein remodeling in remote non-ischemic myocardium in a mouse model of myocardial ischemia and reperfusion |
| Q36915712 | Towards comprehensive cardiac repair and regeneration after myocardial infarction: Aspects to consider and proteins to deliver. |
| Q37058562 | Using the laws of thermodynamics to understand how matrix metalloproteinases coordinate the myocardial response to injury |
| Q37554908 | Ventricular remodeling and function: insights using murine echocardiography |
Search more.